4th Quarter - Report

TWENTY-FIRST CENTURY GROUP, INC. for SANOFI US

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Vaccine related issues and general biological issues, including biodefense and H.R. 2985, the Combination Drug Development Act of 2013.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JACK FIELDS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2985 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.